Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome

Both drugs were discontinued and she improved within 4-7 days. Since hydroxychloroquine is associated with more hypersensitivity reactions than azathioprine, the latter was reintroduced, but 2 days later, the patient developed severe recurrent skin lesions ( figure 1 A-C).

Saved in:

Bibliographic Details
Published in:	BMJ case reports Vol. 2015; p. bcr2015211157
Main Authors:	Vazquez-Sanabria, Irma L, Mercado-Seda, Rogelio, Varela-Rosario, Noemi, Vila, Luis M
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group LTD 22-07-2015 BMJ Publishing Group
Subjects:	Adult Azathioprine - adverse effects Azathioprine - therapeutic use Edema Female Humans Images In Immunoglobulins Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - therapeutic use Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Lupus Lupus Erythematosus, Systemic - drug therapy Other South/Central America Stevens-Johnson Syndrome - drug therapy Stevens-Johnson Syndrome - etiology Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Both drugs were discontinued and she improved within 4-7 days. Since hydroxychloroquine is associated with more hypersensitivity reactions than azathioprine, the latter was reintroduced, but 2 days later, the patient developed severe recurrent skin lesions ( figure 1 A-C).
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	1757-790X 1757-790X
DOI:	10.1136/bcr-2015-211157